NCT00216866View on ClinicalTrials.gov

The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Embolism and Thrombosis
Interventions
DRUG

Dalteparin

DRUG

Warfarin

Trial Locations (6)

B3H 1Y8

Queen Elizabeth II Health Care Centre, Halifax

L8N 4A6

St. Joseph's Healthcare, Hamilton

N6A 4G5

London Health Sciences Centre, London

KiY 4B1

Ottawa General Hospital, Ottawa

KiY 4E9

Ottawa Civic Hospital, Ottawa

H3T 1E2

Sir Mortimer B. Davis Jewish General Hospital, Montreal

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER